Sara Mastaglio

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Cytarabine as a salvage mobilization strategy after failure of cyclophosphamide-based stem cell collection for Daratumumab-treated multiple myeloma patients.

Cytarabine as a salvage mobilization strategy after failure of cyclophosphamide-based stem cell collection for Daratumumab-treated multiple myeloma patients.

Journal: Leukemia & lymphoma

Published: May 08, 2026

The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia.

The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia.

Journal: Frontiers in immunology

Published: February 26, 2026

Long-term remission of neuromyelitis optica with allogeneic hematopoietic stem cell transplant.

Long-term remission of neuromyelitis optica with allogeneic hematopoietic stem cell transplant.

Journal: Med (New York, N.Y.)

Published: October 30, 2025

IL-1 signaling and inflammasomes in acute myeloid leukemia: mechanisms and therapeutic opportunities.

IL-1 signaling and inflammasomes in acute myeloid leukemia: mechanisms and therapeutic opportunities.

Journal: Cellular and molecular life sciences : CMLS

Published: August 19, 2025

Real-life management of 476 older adults with Philadelphia-negative acute lymphoblastic leukemia: a Campus ALL study.

Real-life management of 476 older adults with Philadelphia-negative acute lymphoblastic leukemia: a Campus ALL study.

Journal: Haematologica

Published: June 25, 2025

CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.

CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.

Journal: Current research in translational medicine

Published: May 26, 2025

Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All Study.

Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All Study.

Journal: Hematological oncology

Published: May 20, 2025

Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.

Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.

Journal: American journal of hematology

Published: March 28, 2025

Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.

Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.

Journal: Bone marrow transplantation

Published: March 03, 2025

Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19.

Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19.

Journal: Haematologica

Published: December 06, 2024

Impact of Respiratory Syncytial Virus (RSV) on adult haematology oncology patients.

Impact of Respiratory Syncytial Virus (RSV) on adult haematology oncology patients.

Journal: The Journal of infection

Published: October 17, 2024

Risk stratification and impact of donor type on breakthrough invasive fungal infections in haematopoietic cell transplant with post-transplant cyclophosphamide and mould-active prophylaxis.

Risk stratification and impact of donor type on breakthrough invasive fungal infections in haematopoietic cell transplant with post-transplant cyclophosphamide and mould-active prophylaxis.

Journal: Bone marrow transplantation

Published: September 28, 2024

Showing 1-12 of 58

Last Updated: 09/26/2026